The measurement of metabolites in patients at high risk of major cardiovascular events (MACE) revealed a linear relationship between the occurrence of such events and the plasma concentration of the artificial sweetener erythritol in the 3 years before. After adjustment, the risk was almost doubled when comparing the upper quartile with the lower quartile. Background […]
The official death toll from the shipwreck off the coast of Steccato di Cutro in Calabria, southern Italy, recently had to be corrected from 70 to 72 – a woman and a 3-year-old girl. They belonged to a group of almost 200 Migrants who left Turkey, but whose wooden ship was smashed against rocks in rough […]
In In recent weeks, headlines have once again appeared on red wine and cardiovascular health. Why do these stories suddenly reappear? This is partly due to an article recently published in the «American Journal of Clinical Nutrition» . The «Weinflora study«, funded in part by the São Paulo Research Foundation (FAPESP), was conducted by prominent […]
The At its meeting in February 2023, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the following two medicinal products for approval: pegunigalsidase alfa (Elfabrio, Chiesi Farmaceutici) Recombinant human α-galactosidase-A should be indicated as long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of Fabry […]
Florence, 2 Feb. — (Adnkronos Salute) — There are about 5 million and 623 thousand euros of resources available to the PNRR, the national recovery and resilience plan, to be used in Tuscany for the purchase of instruments and machinery to be made available to the health prevention system from environmental and climate risks, of […]
Conclusions 4 Trial OlympiA survival data demonstrate superiority over placebo in high-risk human epidermal growth factor receptor receptor 2 negative early breast cancer in women with pathogenic or possibly pathogenic germline variants of the BRCA1 or BRCA2 (gBRCA1/2pv). Why it matters This is the second prespecified interim analysis of olaparib’s benefits in high-risk early-stage breast cancer. […]
Source — https://www.univadis.de/viewarticle/lauterbach-will-mehr-digitales-und-die-chirurgen-2023a1000551
Milan, 24 Mar. (Adnkronos Health) — «We must all work together to ensure that our national health system returns to being a point of reference for all citizens and can be able to respond in the best possible way to health requests». This was stated by the Minister of Health Orazio Schillaci, who last night […]
The The theme of this year’s World Hearing Day «Hearing care for all» is particularly relevant for Europe, where access to hearing care varies greatly in different countries and regions. Estimated 197 Millions of people in Europe suffer from some form of hearing loss. According to a World Health Organization report on hearing from the […]
Milan, 3 mar. (Adnkronos Health) — Tomorrow, March 4, we celebrate the World Day to fight the human Papillomavirus HPV, the first cause of cervical cancer. On the occasion of the HPV Day, Lilt, the Italian League for the fight against cancer, in collaboration with the National Cancer Institute-Int of Milan, announces the launch of […]